{
    "id": 3920,
    "fullName": "PIK3CA V344G",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "PIK3CA V344G lies within the C2 PI3K-type domain of the Pik3ca protein (UniProt.org). V344G has not been biochemically characterized, but is predicted to confer a gain of function on the Pik3ca protein as demonstrated by increased transformation ability in two different cell lines (PMID: 29533785).",
            "references": [
                {
                    "id": 11238,
                    "pubMedId": 29533785,
                    "title": "Systematic Functional Annotation of Somatic Mutations in Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29533785"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5290,
        "geneSymbol": "PIK3CA",
        "terms": [
            "PIK3CA",
            "CLAPO",
            "CLOVE",
            "CWS5",
            "MCAP",
            "MCM",
            "MCMTC",
            "p110-alpha",
            "PI3K",
            "PI3K-alpha"
        ]
    },
    "variant": "V344G",
    "createDate": "03/19/2015",
    "updateDate": "07/24/2018",
    "referenceTranscriptCoordinates": {
        "id": 172260,
        "transcript": "NM_006218",
        "gDna": "chr3:g.179203761T>G",
        "cDna": "c.1031T>G",
        "protein": "p.V344G",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 5183,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, YM-024 did not inhibit proliferation of glioblastoma cell lines harboring PIK3CA V344G in culture (PMID: 24718026).",
            "molecularProfile": {
                "id": 3729,
                "profileName": "PIK3CA V344G"
            },
            "therapy": {
                "id": 2967,
                "therapyName": "YM-024",
                "synonyms": null
            },
            "indication": {
                "id": 3068,
                "name": "glioblastoma multiforme",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 4902,
                    "pubMedId": 24718026,
                    "title": "Targeting class IA PI3K isoforms selectively impairs cell growth, survival, and migration in glioblastoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24718026"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10772,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination of BGJ398 and Pictilisib (GDC-0941) resulted in a synergistic effect, demonstrating inhibition of cell proliferation, decreased colony formation, and cell death in an endometrial cancer cell line harboring FGFR2 C383R, PIK3CA E978K and V344G, PIK3R1 N707del, and PTEN mutant in culture, and tumor regression in xenograft models (PMID: 28119489).",
            "molecularProfile": {
                "id": 29846,
                "profileName": "FGFR2 C383R PIK3CA V344G PIK3CA E978K PIK3R1 N707del PTEN mut"
            },
            "therapy": {
                "id": 5613,
                "therapyName": "BGJ398 + Pictilisib",
                "synonyms": null
            },
            "indication": {
                "id": 1380,
                "name": "endometrial cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8811,
                    "pubMedId": 28119489,
                    "title": "PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2mutant Endometrial Cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28119489"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10775,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination of BGJ398 and Buparlisib (BKM120) resulted in a synergistic effect, demonstrating inhibition of cell proliferation, decreased colony formation, and cell death in an endometrial cancer cell line harboring FGFR2 C383R, PIK3CA E978K and V344G, PIK3R1 N707del, and PTEN mutant in culture (PMID: 28119489).",
            "molecularProfile": {
                "id": 29846,
                "profileName": "FGFR2 C383R PIK3CA V344G PIK3CA E978K PIK3R1 N707del PTEN mut"
            },
            "therapy": {
                "id": 5612,
                "therapyName": "BGJ398 + Buparlisib",
                "synonyms": null
            },
            "indication": {
                "id": 1380,
                "name": "endometrial cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8811,
                    "pubMedId": 28119489,
                    "title": "PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2mutant Endometrial Cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28119489"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10773,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination of BGJ398 and Alpelisib (BYL719) resulted in a synergistic effect, demonstrating inhibition of cell proliferation, decreased colony formation, and cell death in an endometrial cancer cell line harboring FGFR2 C383R, PIK3CA E978K and V344G, PIK3R1 N707del, and PTEN mutant in culture, and tumor regression in xenograft models (PMID: 28119489).",
            "molecularProfile": {
                "id": 29846,
                "profileName": "FGFR2 C383R PIK3CA V344G PIK3CA E978K PIK3R1 N707del PTEN mut"
            },
            "therapy": {
                "id": 1293,
                "therapyName": "Alpelisib + BGJ398",
                "synonyms": null
            },
            "indication": {
                "id": 1380,
                "name": "endometrial cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8811,
                    "pubMedId": 28119489,
                    "title": "PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2mutant Endometrial Cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28119489"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3729,
            "profileName": "PIK3CA V344G",
            "profileTreatmentApproaches": [
                {
                    "id": 18088,
                    "name": "Akt1 Inhibitor",
                    "profileName": "PIK3CA V344G"
                },
                {
                    "id": 18093,
                    "name": "mTOR Inhibitor",
                    "profileName": "PIK3CA V344G"
                },
                {
                    "id": 18089,
                    "name": "Akt Inhibitor (Pan)",
                    "profileName": "PIK3CA V344G"
                },
                {
                    "id": 18092,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "PIK3CA V344G"
                },
                {
                    "id": 18087,
                    "name": "PIK3CA inhibitor",
                    "profileName": "PIK3CA V344G"
                },
                {
                    "id": 18090,
                    "name": "PI3K Inhibitor (Pan)",
                    "profileName": "PIK3CA V344G"
                },
                {
                    "id": 18091,
                    "name": "mTORC2 Inhibitor",
                    "profileName": "PIK3CA V344G"
                },
                {
                    "id": 18094,
                    "name": "Akt2 Inhibitor",
                    "profileName": "PIK3CA V344G"
                }
            ]
        },
        {
            "id": 29791,
            "profileName": "FGFR2 C382R PIK3CA V344G PIK3CA E978K PIK3R1 N707del PTEN mut",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 29846,
            "profileName": "FGFR2 C383R PIK3CA V344G PIK3CA E978K PIK3R1 N707del PTEN mut",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 172259,
            "transcript": "XM_006713658",
            "gDna": "chr3:g.179203761T>G",
            "cDna": "c.1031T>G",
            "protein": "p.V344G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 172261,
            "transcript": "XM_011512894",
            "gDna": "chr3:g.179203761T>G",
            "cDna": "c.1031T>G",
            "protein": "p.V344G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 172260,
            "transcript": "NM_006218",
            "gDna": "chr3:g.179203761T>G",
            "cDna": "c.1031T>G",
            "protein": "p.V344G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}